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igration of undifferentiated neural progenitors is
critical for the development and repair of the ner-
vous system. However, the mechanisms and factors
that regulate migration are not well understood. Here, we
show that vascular endothelial growth factor (VEGF)-A, a
major angiogenic factor, guides the directed migration of
neural progenitors that do not display antigenic markers for
neuron- or glia-restricted precursor cells. We demonstrate
that progenitor cells express both VEGF receptor (VEGFR) 1
M
 
and VEGFR2, but signaling through VEGFR2 speciﬁcally
mediates the chemotactic effect of VEGF. The expression of
VEGFRs and the chemotaxis of progenitors in response to
VEGF require the presence of ﬁbroblast growth factor 2.
These results demonstrate that VEGF is an attractive guidance
cue for the migration of undifferentiated neural progenitors
and offer a mechanistic link between neurogenesis and
angiogenesis in the nervous system.
 
Introduction
 
Migration of immature neurons during development is
essential for the proper formation of the nervous system. In
the mammalian brain, most neurons are generated within
proliferative zones around the ventricle from where immature
precursors migrate to specific sites in the cerebral wall
(Marin and Rubenstein, 2003). A variety of clinical syn-
dromes, including various forms of Lissencephalies, are
related to deficient migration of neural cells (Ross and Walsh,
2001). The consequences of these malformations include
mental retardation, epilepsy, paralysis, and blindness. Genetic
studies of some of these perturbations have provided some
understanding of the regulation of neuronal migration. The
genetic repertoire that is required for neuronal migration has
rapidly expanded over the past 10 yr (Rubenstein and Rakic,
1999; Ross and Walsh, 2001). In addition to playing a key
role in early development, neuronal migration is also impor-
tant for the adult brain. For example, in the brain of song-
birds, neurogenesis and neuronal migration are required for
structural plasticity and learning throughout adulthood
(Goldman and Nottebohm, 1983). Recent evidence suggests
that undifferentiated multipotential progenitors also exist in
the adult mammalian brain and during adult neurogenesis,
as well as during the continuous neuronal replacement that
occurs at specific sites in the rostral subventricular zone
(SVZ)–olfactory bulb system and the dentate gyrus (Alvarez-
Buylla and Garcia-Verdugo, 2002; Marshall et al., 2003).
Finally, cell migration plays a central role in wound repair.
Although the intrinsic capacity of the adult mammalian
brain to replace lost or damaged neurons is very limited, mi-
gration of neural progenitors and cell replacement has been
reported after administration of growth factors such as FGF-2
as well as after transplantation of purified progenitors (Kuhn
et al., 1997; Arvidsson et al., 2002; Ben-Hur et al., 2003).
Considerable effort has recently been focused on under-
standing the factors and mechanisms involved in the navigation
of immature neurons to their final destination. Highly
conserved families of attractive and repulsive molecules are
coordinately regulated to guide neurons to their final desti-
nation. These families include netrins, semaphorins, ephrins,
Slits, and various neurotrophic factors (Marin and Rubenstein,
2003; Marin et al., 2003). Compared with migration of
postmitotic immature neurons, little is known about the
factors and mechanisms that direct the migration of neural
stem cells and undifferentiated progenitors. In one study,
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PDGF was shown to attract FGF-2–stimulated neural pro-
genitors in a transfilter migration assay (Forsberg-Nilsson et
al., 1998). Identifying candidate molecules that could play a
role in this process is crucial not only for understanding
proper tissue formation during development but also for de-
veloping methods for directing undifferentiated progenitors
to achieve structural brain repair. Here, we report that
VEGF-A is one such molecule.
VEGF belongs to a family of glycoproteins that plays an
essential role in the development of blood vessels (vasculo-
genesis), the generation of new vascular networks from exist-
ing vessels (angiogenesis), and hematopoiesis (Matsumoto
and Claesson-Welsh, 2001; Robinson and Stringer, 2001).
The VEGF gene family has at least five members in mam-
mals including VEGF-A, VEGF-B, VEGF-C, VEGF-D,
and placenta growth factor (Matsumoto and Claesson-
Welsh, 2001). These secreted molecules bind with high af-
finity to tyrosine kinase receptors including VEGF receptor
(VEGFR) 1 (Flt-1), VEGFR2 (KDR/Flk1), VEGFR3 (Flt-
4), and neuropilin-1 and -2. As a result of the receptor acti-
vation and subsequent signal transduction, VEGF target
cells may proliferate, migrate, or alter gene expression; e.g.,
of matrix metalloproteases or cytokines. Recent evidence
suggests that VEGF is expressed in neural cells and plays a
role in diverse aspects of brain development including ax-
onal growth (Sondell et al., 1999, 2000), cell survival (Son-
dell et al., 1999; Jin et al., 2000; Ogunshola et al., 2002),
and neuroprotection against glutamate toxicity (Matsuzaki
et al., 2001; Svensson et al., 2002). Moreover, it has been
suggested that VEGF can enhance neurogenesis in the SVZ
in vivo as well as in vitro (Jin et al., 2002).
Angiogenesis and neurogenesis occur concurrently in the
adult dentate gyrus (Palmer et al., 2000) and in the songbird
brain (Louissaint et al., 2002). These observations raised the
intriguing possibility that VEGF could function as a com-
mon factor to recruit both endothelial cells and neurogenic
progenitors to specific sites. To test this hypothesis, we puri-
fied neural progenitors from the SVZ of newborn rats and
expanded the cells with FGF-2. In a cell-based chemotaxis
assay, we demonstrate that concentration gradients of VEGF
induce directional sensing by neural progenitor cells. Che-
moattraction by VEGF was mediated by signaling through
VEGFR2. Moreover, we observed that FGF-2 increases ex-
pression of VEGFRs in neural progenitors, and that the che-
motactic response of progenitor cells only occurs in the pres-
ence of FGF-2. Finally, cocultures of SVZ explants with
cells secreting VEGF in a three-dimensional collagen gel ma-
trix confirmed that VEGF acts as a chemoattractant for neu-
ral progenitors.
 
Results
 
To investigate the potential role of VEGF in the regulation
of FGF-2–stimulated neural progenitor migration, SVZ cells
were isolated from newborn rats and cultured in the pres-
ence of FGF-2 in defined medium as described previously
(Lim et al., 2000). 4 d after plating, the cells had an imma-
ture, round, or bipolar morphology (Fig. 1 A). Daily obser-
vations indicated that cells divided, formed loose colonies,
and, by day 6, formed a monolayer (Fig. 1 B). At this stage,
the vast majority (98%) of cells were stained with an Ab
(Fig. 1 C), which is considered to be a marker of neural pro-
genitors. Less than 3.2% of the cells expressed the neuronal
marker Tuj; PSA-NCAM and BrdU incorporation showed
that these cells did not divide (Fig. 1 D). Very few to no cells
displayed immunoreactivity for GFAP or Gal C, markers for
astrocytes and oligodendrocytes, respectively (unpublished
data). With the exception of the few differentiated cells, pro-
genitor cells maintained in the presence of FGF-2 did not
display antigenic markers for neuron- or glia-restricted pre-
cursor cells including PSA-NCAM, doublecortin, NeuN,
NG2, or A2B5 (unpublished data). In addition, nestin-posi-
tive cells were negative for endothelial markers such as von
Willebrand factor and RECA-1 (unpublished data). These
results indicate that the cultures consist of immature cells
that do not yet possess cell lineage-specific markers for neu-
rons or glial cells. When cultures were allowed to differenti-
ate under conditions shown previously to stimulate both
neuronal and glial differentiation (Palmer et al., 1997),
 
 
 
96% of the population displayed immunoreactivity for
neuronal and astrocytic markers (Tuj
 
 
 
, 21%; GFAP
 
 
 
,
75%; Fig. 1 E). The remaining population was immunore-
active for oligodendrocyte markers A2B5 or Gal C (Fig. 1
F). These observations concur with earlier studies (Tropepe
et al., 1999) showing that FGF-2–expanded cells are multi-
potential neural progenitors that can give rise to neurons, as-
Figure 1. Morphological and immunocytochemical characterization 
of neural progenitors in culture. Neural progenitors were isolated 
and purified from the SVZ of newborn rat brains and cultured on 
matrigel-coated coverslips in the presence of 20 ng/ml FGF-2. 
(A and B) Phase-contrast images of neural progenitors at day 4 (A) 
and day 6 (B) in culture. (C) After 6 d in culture, the majority of cells 
are immunopositive for nestin, indicating that they are undifferentiated 
neural progenitors. (D) BrdU incorporation (red) showing that the 
majority of cells are proliferating. The rare cells that are positive for 
the neuronal marker (TuJ, green, arrow) are nonproliferative. (E and F) 
5 d after the withdrawal of FGF-2, cells differentiate into GFAP-
containing astrocytes (E, red), Tuj-positive neurons (E, green), and 
GalC-positive oligodendrocytes (F, green). Cell nuclei were counter-
stained with Hoechst 33342 in C, E, and F. Bar: (A and B) 80  m; 
(C) 30  m; (D) 19  m; (E and F) 30  m. 
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trocytes, and oligodendrocytes, the three major cell types in
the central nervous system.
 
Chemoattraction of FGF-2–stimulated progenitors 
by VEGF
 
Next, we examined the response of neural progenitors to gra-
dients of VEGF in the direct-viewing Dunn chemotaxis
chamber (Zicha et al., 1991; Allen et al., 1998). This appara-
tus allows for direct monitoring of cell locomotion, including
analysis of migration speed, turning behavior, and directional-
ity (see Materials and methods). It has been established that
chemoattractants added to the outer well of the Dunn cham-
ber diffuse across the bridge to the inner well (Fig. 2, A and B)
and form a linear steady gradient within 
 
 
 
30 min of setting
 
up the chamber (Zicha et al., 1991; Webb et al., 1996). The
gradient remains stable for 
 
 
 
30 h thereafter (Zicha et al.,
1991; Webb et al., 1996). To study the chemotaxis of neural
progenitors, the outer well of the Dunn chamber was filled
with medium containing different concentrations of VEGF
and the concentric inner well with medium only. Coverslips
with progenitor cells were inverted onto the chamber, and cell
locomotion (Fig. 2) was recorded over one part of the bridge
region. We observed that progenitors at day 6 maintained in
the presence of FGF-2 and exposed to concentration gradients
established with 200 ng/ml VEGF displayed strong positive
chemotaxis (Fig. 2 C). The scatter diagram of cell displace-
ments in Fig. 2 C demonstrates a strong directional bias of
migration toward the source of VEGF. In contrast, when
VEGF was added to both inner and outer wells (chemokinesis
conditions), cells remained motile but the population as a
whole showed no clear preference for displacement (Fig. 2 D).
In these experiments, 20 ng/ml FGF-2 was systematically in-
cluded in the medium during the recording of neural progen-
itor chemotaxis or chemokinesis. However, FGF-2 had no
chemotactic effect on these cells, irrespective of whether or
not VEGF was present (Fig. 2, E and F). No difference was
detected in the migratory behavior between cells exposed to
an FGF-2 gradient (Fig. 2 E) and cells exposed to a uniform
concentration of FGF-2 (Fig. 2 F).
These observations were confirmed by the examination of
individual cell tracks. As shown in Fig. 3, progenitors exposed
to a VEGF gradient migrated efficiently toward the source of
VEGF (Fig. 3, A and B), whereas those under conditions of
chemokinesis (Fig. 3, C and D) or exposed to an FGF-2 gra-
dient (not depicted) made random turns during migration.
To measure the efficiency of directed cell migration, we cal-
culated each cell’s forward migration index (FMI), i.e., the ra-
tio of the most direct distance the cell progressed toward the
gradient source (the outer well of the Dunn chamber) over its
total path length. These quantitative analyses revealed that
both the migration speed (Fig. 4 A) and the FMI (Fig. 4 B) of
cells exposed to VEGF in the presence of FGF-2 were signifi-
cantly greater than those of cells exposed to an FGF-2 gradi-
ent or to a uniform concentration of VEGF or FGF-2
(chemokinesis). The attractive effect of VEGF was similar on
laminin-, poly-
 
L
 
-lysine–, or matrigel-coated coverslips. These
data indicate that VEGF is attractant for FGF-2–stimulated
neural progenitors, and that this effect is matrix independent.
 
VEGFR expression in progenitors
 
Signaling receptors for VEGF include VEGFR1 (Flt-1) and
VEGFR2 (KDR/Flk-1), both of which belong to the receptor
tyrosine kinase superfamily (Matsumoto and Claesson-Welsh,
2001). To determine whether these receptors are expressed by
FGF-2–stimulated progenitors, total cellular RNA was ana-
lyzed by RNase protection assay. This revealed that the cells
express VEGFR1 and VEGFR2 when cultured in the pres-
ence of FGF-2. mRNA for VEGFR3 was not detected in
these cultures (Fig. 5 A). Previous studies have indicated that
in endothelial cells, FGF-2 regulates expression of VEGFRs
(Pepper and Mandriota, 1998). To explore whether FGF-2
affects the expression of these receptors in FGF-2–stimulated
progenitors, mRNAs for VEGFR1 and VEGFR2 were ana-
lyzed after 12-h starvation of FGF-2. We found that with-
Figure 2. VEGF stimulates chemotaxis of neural progenitors. 
(A) Schematic representation of Dunn chamber (top view) with the 
overlying coverslip, showing the position of the inner well, bridge, 
and outer well. (B) Cells over the annular bridge between the inner 
and outer wells of the chamber can be observed under phase-contrast 
optics. Arrow indicates the direction of the outer well of the Dunn 
chamber. Bar, 50  m. Cell migration was recorded continuously by 
time-lapse frame grabbing, and the migration tracks were plotted in 
scatter diagrams (C–F) as described in Materials and methods. The 
starting point for each cell is the intersection between the X and Y 
axes (0,0), and data points indicate the final positions of individual 
cells at the end of the 2-h recording period. Chemotaxis was tested 
by placing 200 ng/ml VEGF (C) or FGF-2 (E) in the outer well. The 
direction of the gradient is vertically upwards. Note that neural pro-
genitors undergo chemotaxis and display a clear directionality of 
migration in the presence of a VEGF (C) but not an FGF-2 gradient (E). 
For chemokinesis (D and F), equal amounts of VEGF (20 ng/ml) or 
FGF-2 (20 ng/ml) were added in both the inner and outer wells of 
the chamber.  
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drawal of FGF-2 led to a marked, fivefold decrease in the level
of VEGFR1 and VEGFR2 transcripts (Fig. 5, A and B).
These results demonstrate that FGF-2–stimulated progenitors
express mRNA for both VEGFR1 and VEGFR2 and that
FGF-2 is required for this expression.
 
VEGF-induced chemotaxis is mediated 
through VEGFR2
 
To identify the receptors involved in VEGF-induced che-
motaxis, we analyzed the migratory behavior of cells toward
Figure 3. Migration tracks of neural 
progenitors. (A) Phase-contrast photos 
showing a representative cell (*) migrating 
up a VEGF gradient. Arrow indicates the 
source of VEGF. (B) Migration tracks of 
four representative cells in the presence 
of a VEGF concentration gradient. The 
starting point for each cell is the inter-
section between the X and Y axes (0,0), 
and the source of VEGF is at the top. (C) 
Phase-contrast photos showing a neural 
progenitor that randomly migrates in a 
uniform concentration of VEGF. Arrow 
indicates the outer well of the Dunn 
chamber. (D) Migration tracks of four 
representative cells that migrate randomly 
under conditions of uniform VEGF 
distribution. The starting point for each 
cell is the intersection between the X 
and Y axes (0,0).
Figure 4. The migration speed ( m/hr) and FMI values under 
different conditions. (A) Cell migration speed was calculated for 
each time-lapse interval and the mean speed was derived for a period 
of 2 h. Data are shown as mean   SEM from at least three independent 
experiments. FMI values (B), as described in Materials and methods, 
can be either positive or negative, depending on the direction in 
which the cells migrate. *, P   0.01 by two-tailed unpaired t test, 
significantly different from chemokinesis or an FGF-2 gradient.
Figure 5. VEGFR expression in neural progenitors. (A) Total cellular 
RNA was isolated and VEGFR mRNA expression was assessed by 
RNase protection analysis. Purified 
32P-labeled rat cRNA probes 
(Probe) were hybridized to hybridization mix (Probe   h.m.), yeast 
tRNA, or total RNA from cells grown in FGF-2 or starved of FGF-2 
for 12 h. Rat acidic ribosomal phosphoprotein (P0) was used as an 
internal control. Rat lung was used as a positive control. (B) Quanti-
tative analysis of VEGFR1 and VEGFR2 expression in cells cultured 
in the presence of FGF-2 or starved of FGF-2 for 12 h. Data are 
shown as the mean   SEM from three independent experiments. 
*, P   0.01 by two-tailed unpaired t test, significantly different from 
cells in FGF-2 (n   3). 
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VEGF in the presence of functional blockers (neutralizing
Abs) of VEGFR1 or VEGFR2. As shown in Fig. 6, the che-
motactic response of cells to VEGF was completely abro-
gated by the VEGFR2-blocking Ab DC101 (Fig. 6, A and
C). In contrast, the VEGFR1-blocking Ab MF1 did not af-
fect chemotaxis (Fig. 6 A). These observations were con-
firmed by measurements of speed and FMI (Fig. 6 B). In the
absence of a VEGF gradient, addition of anti-VEGFR2 had
no significant effect on progenitor migration. These experi-
ments demonstrate that VEGF stimulates chemotaxis of
progenitor cells through VEGFR2. This conclusion received
further support from experiments in which concentration
gradients of VEGF-C
 
 
 
N
 
 
 
C
 
 were used to induce chemotaxis.
We observed that VEGF-C
 
 
 
N
 
 
 
C
 
 could efficiently induce
chemotaxis of progenitor cells and that this effect was
prevented by the VEGFR2-blocking Ab (unpublished
data). Furthermore, because VEGF-C
 
 
 
N
 
 
 
C
 
 exerts its function
through VEGFR2 and VEGFR3, and because VEGFR3
is not expressed by FGF-2–stimulated neural progeni-
tors, these results strengthen the conclusion that signaling
through VEGFR2 mediates chemoattraction of progenitor
cells by VEGF.
 
FGF-2 is required for VEGF to stimulate chemotaxis 
of progenitor cells
 
Inasmuch as FGF-2 is required for the expression of
VEGFR2, the chemotactic response of progenitor cells to
VEGF should also be dependent on the presence of FGF-2.
To test this hypothesis, we examined the migratory response
of progenitors to VEGF in the absence of FGF-2. Cells at
5 d of culture were starved of FGF-2 for 12 h, and then ex-
posed to a VEGF gradient (Fig. 7 A). As shown in Fig. 7 B,
starved cells failed to undergo chemotaxis in response to
VEGF. Cells migrated randomly in a manner similar to
when they were exposed to a uniform concentration of
VEGF. In agreement with these results and confirming the
data of the RNase protection assay (Fig. 5), Western blot
analysis revealed little to no expression of VEGFR2 protein
in the absence of FGF-2, whereas substantial expression was
detected in the presence of FGF-2 (Fig. 7 E).
Next, we assessed whether the effect of FGF-2 withdrawal
is reversible and whether cells could chemotactically respond
to VEGF upon readdition of FGF-2 to the cultures. To this
end, FGF-2 was included in the medium after a 12-h starva-
tion period, and the cells were further cultured for 8 h. Dia-
grams of displacements of motile cells (Fig. 7 C) and a quan-
titative analysis of FMI and speed (Fig. 7 D) demonstrated
that the loss of chemotaxis was rescued after an 8-h reincu-
bation with FGF-2. Together, these data demonstrate that
FGF-2 is necessary for the expression of VEGFR2 and for an
adequate migratory response of progenitors to concentration
gradients of VEGF.
 
VEGF affects the migration of progenitor cells 
from the SVZ
 
To determine whether the effect of VEGF on FGF-2–stimu-
lated progenitor migration is functionally relevant, we inves-
tigated the effect of VEGF on cell migration from SVZ ex-
plants. SVZ explants were cocultured in a three-dimensional
collagen matrix with aggregates of control or VEGF-secret-
ing murine C
 
2
 
C
 
12
 
 myoblasts in the presence or absence of
FGF-2. When explants were cocultured with aggregates of
mock-transfected cells in the presence of 20 ng/ml FGF-2
(Fig. 8, B and D), migrating cells were symmetrically dis-
tributed around the explants (10/10 explants). When SVZ
explants were cocultured in the presence of FGF-2, with
Figure 6. VEGF stimulates chemotaxis of neural 
progenitors through VEGFR2. (A) Scatter plots showing 
the migation patterns of neural progenitors under 
control conditions or in the presence of VEGFR blockers. 
Cells treated with the VEGFR2-blocking Ab (DC101) 
lost the chemotactic response to VEGF. In contrast, the 
VEGFR1-blocking Ab (MF1) did not affect progenitor 
migration. (B) Speed and FMI under different migration 
conditions. Data are shown as the mean   SEM from 
three independent experiments. *, P   0.01 by two-
tailed unpaired t test, significantly different from DC101-
treated cells. (C and D) Migration tracks of representative 
cells (four for each condition) exposed to a VEGF 
concentration gradient, in the presence of either 
VEGFR2-blocking Ab (C) or control (polysialic acid 
blocking) Ab (D). The starting point for each cell is the 
intersection between the X and Y axes (0,0), and the 
source of VEGF is at the top in the gradient condition. 
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VEGF-expressing cells placed on one side and with mock-
transfected cells on the other, cell migration was highly
asymmetric (Fig. 8, A and E; 10/20 explants with cells mi-
grating predominantly toward VEGF-secreting C
 
2
 
C
 
12
 
 cells,
and 10/20 explants with a symmetric migratory pattern). In
contrast, when explants were cocultured with control or
VEGF-expressing cells in the absence of FGF-2, no signifi-
cant cell migration from SVZ explants was observed (Fig. 8
C; 10/10 explants). Similar results were obtained after appli-
cation of VEGF in the absence of FGF-2 (4/4 explants). The
application of VEGF and FGF-2 together or FGF-2 alone
resulted in symmetric migration (12/12). To determine
whether cells migrating in response to VEGF are immature
progenitors, we performed immunocytochemical staining
with an antinestin Ab. Migrating cells stained positively for
nestin (Fig. 8 F) and were negative for PSA-NCAM (a
marker for immature neurons; not depicted), confirming
that they were indeed immature progenitor cells. Together,
these results indicate that immature progenitor cells migrate
in response to VEGF gradients and that FGF-2 is required
for this effect.
 
Discussion
 
Previous studies have suggested that neurogenesis and angio-
genesis are mechanistically linked in the nervous system
(Palmer et al., 2000; Louissaint et al., 2002). Here, we re-
port that VEGF, a major angiogenic factor that has been
identified as a guidance factor for endothelial progenitors
and hematopoietic cells (Matsumoto and Claesson-Welsh,
2001; Robinson and Stringer, 2001) is a chemoattractant for
immature neural progenitors. We show that although FGF-
2–stimulated progenitor cells express both VEGFR1 and
VEGFR2, signaling through VEGFR2 appears to specifi-
cally mediate the effect of VEGF. Moreover, VEGFR2 ex-
pression, and consequently the capacity of cells to respond
Figure 7. FGF-2 is required for neural progenitors to 
chemotactically respond to a VEGF gradient. (A) Experimental 
protocol: in the first group of cultures, FGF-2 was withdrawn 
at day 5 for 12 h, and then cells were exposed to a VEGF 
gradient (B). The second group was further cultured in the 
presence of FGF-2 after the 12-h starvation period for 8 h, 
and then tested in a VEGF gradient (C). The final positions of 
the cells after 2 h of migration were indicated, with the starting 
point for each cell at (0,0), and the source of 200 ng/ml VEGF 
at the top. (D) Speed and FMI were calculated as described 
in Materials and methods. Data are shown as mean   SEM 
from four independent experiments. After 12 h of FGF-2 
starvation, cells lose their chemotactic response to the VEGF 
gradient. The starved neural progenitors resume their chemo-
tactic response to VEGF upon readdition of FGF-2 to the 
cultures for 8 h (C). (E) VEGFR2 expression in neural progenitors 
cultured in FGF-2 or starved of FGF-2 for 12 h. Western blot 
analysis was performed on immunoprecipitates with an anti-
VEGFR2 Ab. *, P   0.01 by two-tailed unpaired t test.
Figure 8. Effect of VEGF on neural progenitors 
migrating from SVZ explants. SVZ explants were co-
cultured with VEGF-secreting C2C12 cells and/or 
mock-transfected C2C12 cells in collagen gel matrices 
in the presence (A, B, D, E, and F) or absence (C) of 
FGF-2. (A) In the presence of FGF-2, neural progenitors 
migrate out of the SVZ explant in an asymmetric manner, 
with many more cells on the side of the VEGF-secreting 
C2C12 cells than on the side of control C2C12 cells. 
(B) Neural progenitors migrate out of the SVZ explant 
symmetrically when cultured with control C2C12 cells 
on both sides. (C) In the absence of FGF-2, few to no 
cells migrate out of the SVZ explant. (D) High-power 
photograph showing the SVZ explant on the side of 
control C2C12 cells. (E) High-power photograph showing 
many neural progenitors migrating out of the SVZ 
explant toward VEGF-secreting C2C12 cells. (F) Cells 
migrating out of the SVZ explant are positive for nestin, 
a marker for undifferentiated neural progenitors. 
Bars: (A–C) 700  m; (D and E) 100  m; (F) 50  m. 
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to gradients of VEGF, critically depends on the presence of
FGF-2. Finally, we demonstrate that migration of progeni-
tors from SVZ explants in a three-dimensional collagen ma-
trix is directed by VEGF. This effect also requires the pres-
ence of FGF-2. These results reveal an intriguing signaling
mechanism that guides migrating neural progenitors in the
central nervous system. They also support the hypothesis
that a common guiding mechanism exists for neurogenic
progenitors and endothelial cells.
Our immunocytochemical characterization revealed that
progenitor cells maintained in the presence of FGF-2 do not
display antigenic markers for neuron- or glia-restricted pre-
cursor cells, including PSA-NCAM, doublecortin, NeuN,
NG2, or A2B5. Most remarkable is the absence of NCAM
immunoreactivity in these cells. We found very few cells dis-
playing differentiation markers such as tubulin, GFAP, O4,
or Galc. Their presence is probably due to contamination of
the initial cell population after isolation and purification of
progenitors. In contrast, the vast majority (98%) of cells
were stained with an antinestin Ab. Importantly, nestin-pos-
itive cells were negative for endothelial markers such as von
Willebrand factor and RECA-1. Together, these results indi-
cate that our culture model consists of progenitor or stem
cells that do not yet possess cell lineage-specific markers for
neurons or glial cells. It should be emphasized here that pro-
genitor cells in the presence of FGF-2 do not generate neu-
rospheres, but rather spread out evenly and form a mono-
layer. This may expose cells to FGF-2 more evenly and favor
the formation of a homogenous population of undifferenti-
ated progenitors as has previously been suggested (Wu et al.,
2002). Because 
 
 
 
96% of these progenitor cells displayed
immunoreactivity for neuronal and glial markers after differ-
entiation, we conclude that our cultures are composed essen-
tially of multipotential neural progenitors or stem cells.
The Dunn chemotaxis chamber allowed us to show di-
rectly that concentration gradients of VEGF induce direc-
tional sensing by neural progenitor cells. Under basal condi-
tions in the presence of uniform concentrations of FGF-2,
progenitor cells were polarized and motile, and moved ran-
domly across a two-dimensional substrate with a mean speed
of 
 
 
 
58 
 
 
 
m/hr (Fig. 4 A). When cells were exposed to linear
gradients of VEGF, their leading processes became stable
over a substantial portion of the time course, and the cells
continued to migrate up the VEGF gradient. In contrast,
when cells were exposed to uniform concentrations of
VEGF, no biased displacement was observed, and the mean
displacement speed was not significantly different from that
measured in the presence of FGF-2 alone. Thus, although
VEGF specifically affects the direction of progenitor migra-
tion, it does not appear to stimulate migration rate per se.
Similar results were obtained with VEGF-C
 
 
 
N
 
 
 
C
 
. VEGF-
C
 
 
 
N
 
 
 
C
 
 is the proteolytically processed form of VEGF-C (21
kD; which binds to and activates VEGFR2 and 3 (Joukov et
al., 1997). We also demonstrated that the effect of VEGF
and VEGF-C
 
 
 
N
 
 
 
C
 
 was specific because concentration gradi-
ents of FGF-2 did not induce directional migration of neu-
ral progenitor cells. In line with these observations, our ex-
periments with SVZ explants show that FGF-2–stimulated
progenitors are invasive in a three-dimensional collagen ma-
trix in which they migrate toward the source of VEGF.
We observed that FGF-2–stimulated progenitors express
the two tyrosine kinase receptors for VEGF; namely,
VEGFR1 and VEGFR2, but not VEGFR3. These findings
confirm previous observations demonstrating that members
of the VEGFR family are expressed not only by blood and
endothelial cells but also by immature neurons from differ-
ent regions of the nervous system (Carmeliet and Storke-
baum, 2002; Jin et al., 2002; Louissaint et al., 2002; Ogun-
shola et al., 2002; Svensson et al., 2002). Our results extend
these observations by showing that, similar to endothelial
cells (Pepper and Mandriota, 1998), FGF-2 is a critical regu-
latory factor for VEGFR expression in progenitor cells. We
demonstrate that the receptor is expressed in the presence of
FGF-2, and that withdrawal of the growth factor leads to a
significant down-regulation as measured by RNase protec-
tion assay and Western blotting. Consistent with these find-
ings, we demonstrate that migratory responses to VEGF also
require the presence of FGF-2 in the two-dimensional as
well as three-dimensional migration models. It is unlikely
that down-regulation of VEGFR expression and the lack of
chemotactic responses are due to death or suffering of cells
in the absence of FGF-2. The arguments for this are as fol-
lows: (a) after removal of FGF-2 for 12 h, cells maintained
in neurobasal medium supplemented with B27 displayed no
difference in morphology compared with control cultures;
(b) Hoechst 33258 staining of cell nuclei did not reveal any
difference between cultures kept in the presence or absence
of FGF-2; (c) our video analysis revealed that cells in the ab-
sence of FGF-2 exhibited random migration with the same
migration speed as control cells in the presence of FGF-2;
and (d) FGF-2 starvation did not change the expression of
acidic ribosomal phosphoprotein. In vitro, FGF-2 is known
to stimulate mitotic activity in progenitor cells and to main-
tain these cells in an undifferentiated state (Palmer et al.,
1997; Tropepe et al., 1999). Because withdrawal of FGF-2
from cultures is a standard procedure used to induce the dif-
ferentiation of FGF-2–stimulated progenitors (Palmer et al.,
1997; Tropepe et al., 1999), these results raise the intriguing
possibility that the more differentiated progenitors lose
VEGFR expression as well as the capacity to respond to
VEGF. However, the effect of FGF-2 withdrawal was re-
versible upon the reapplication of FGF-2 to the medium af-
ter 8 h. It will be of particular interest to determine whether
VEGFR expression can be induced by FGF-2 in differenti-
ated neurons.
Although FGF-2–stimulated progenitors express both
VEGFR1 and VEGFR2, only the latter appears to be re-
quired for directional migration in response to VEGF. We
observed that by blocking receptor function with a specific
mAb, we could completely block the migratory response to
VEGF. In contrast, function-blocking Abs against VEGFR1
had no effect. These results demonstrate that VEGFR2 sig-
naling, previously shown to regulate survival and prolifera-
tion of neuronal progenitors (Carmeliet and Storkebaum,
2002; Jin et al., 2002; Ogunshola et al., 2002; Svensson et
al., 2002), is also involved in the migration of these cells.
The respective roles of VEGFR1 and VEGFR2 in regulating
cell migration are not well understood. Although similar to
FGF-2–stimulated neural progenitors, the VEGFR2 path-
way appears to be involved in the migration of endothelial 
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cells (Matsumoto and Claesson-Welsh, 2001; Robinson and
Stringer, 2001); in other cells such as a neuroectodermal
cell line from a human cerebellar tumor, and monocytes,
VEGFR1 signaling dominates (Bagnard et al., 2001; Matsu-
moto and Claesson-Welsh, 2001; Robinson and Stringer,
2001; Forstreuter et al., 2002).
The in vivo relevance of our findings remains to be deter-
mined. The observations presented here raise the intriguing
possibility that VEGF signaling could be involved specifi-
cally in directing migration of multipotent neural progeni-
tors rather than in guiding neuron- or glia-restricted precur-
sors. One possibility is that VEGF signaling plays a role in
the initial phase of neurogenesis, in particular in the forma-
tion of neurogenic matrix or neurogenic niches in asso-
ciation with angiogenic sites. Indeed, high levels of VEGF
transcripts were detected in the neurogenic matrix of the
ventricular zone and SVZ in the embryonic, as well as in the
postnatal, rat brain (Breier et al., 1992). Moreover, receptors
for VEGF are expressed in neuroproliferative zones in vivo
(Breier et al., 1995; Jin et al., 2002). Recently, Palmer et al.
(2000) showed that clusters of proliferating cells in the den-
tate gyrus of the adult mammalian brain contain dividing
endothelial as well as neural progenitors. They also demon-
strated that proliferative clusters are associated with growing
capillaries. Some of the cells in the clusters were immunore-
active for VEGFR2, whereas VEGF immunoreactivity was
seen in tissue surrounding the clusters. These observations
were corroborated by experiments showing that neurogene-
sis and angiogenesis occur concurrently in the adult avian
brain (Louissaint et al., 2002). In this system, immature
neurons generated in the subventricular germinal zone mi-
grate to reach active angiogenic spots in the adjacent tissue.
These results are also consistent with studies showing the as-
sociation of neural progenitors with blood vessels (Capela
and Temple, 2002). Based on these results, Palmer et al.
(2000) proposed a model in which neural and angiogenic
progenitors are recruited to form proliferative niches either
by common signaling mechanisms or by cues acting simulta-
neously. Our results lend support to this hypothesis by
demonstrating that VEGF, previously described as a che-
moattractant for endothelial progenitors and blood cells
(Matsumoto and Claesson-Welsh, 2001; Robinson and
Stringer, 2001), is able to direct neural progenitor migra-
tion. Thus, VEGF could be a common guidance cue for re-
cruiting neural progenitors and endothelial cells to correct
sites for differentiation. Such a role is consistent with the ob-
servation that VEGF promotes the survival of both imma-
ture neurons and endothelial cells (Sondell et al., 1999; Mat-
sumoto and Claesson-Welsh, 2001; Robinson and Stringer,
2001), stimulates the proliferation of both cells types (Mat-
sumoto and Claesson-Welsh, 2001; Robinson and Stringer,
2001; Ogunshola et al., 2002), and protects them from in-
jury in vitro (Jin et al., 2000; Matsumoto and Claesson-
Welsh, 2001; Robinson and Stringer, 2001; Matsuzaki et
al., 2001) as well as in vivo (Matsumoto and Claesson-
Welsh, 2001; Robinson and Stringer, 2001; Ogunshola et
al., 2002). The coordinated regulation of neurogenesis and
angiogenesis by VEGF highlights the importance of this sig-
naling pathway in the morphogenesis of nervous tissue.
Our results could also be important in the context of re-
pair after brain injury. Increasing evidence indicates that
VEGF and its receptors are activated after various lesions in
the brain, including stroke (Carmeliet and Storkebaum,
2002). For example, focal or global brain ischemia induces
an acute up-regulation of VEGF expression that is consistent
with the notion that the promoter region of VEGF contains
hypoxia-responsive elements (Carmeliet and Storkebaum,
2002; Zhang and Chopp, 2002; Sun et al., 2003). In addi-
tion, several cytokines and growth factors known to be asso-
ciated with ischemia up-regulate VEGF expression in many
cell types. VEGF expression under these conditions appears
to be important for initiating neovascularization and regen-
erating capillaries in the damaged zone. Injuries to the brain,
including ischemia and seizure, also stimulate the mitotic ac-
tivity of neural progenitors in neurogenic centers and en-
hance neurogenesis (Parent and Lowenstein, 2002; Parent et
al., 2002; Kokaia and Lindvall, 2003; Iwai et al., 2003). Un-
der these circumstances, VEGF could be an attractant guid-
ance factor for neural progenitors, just as it is for endothelial
progenitors and blood cells. Thus, VEGF and FGF-2 appear
to be potential therapeutic molecular tools whose efficacy in
directing the migration of endogenous or transplanted pro-
genitors to injured regions of the brain must be assessed.
 
Materials and methods
 
Isolation and cultures of neural progenitors
 
All animal experiments were conducted in accordance with Swiss laws,
previously approved by the Geneva Cantonal Veterinary Authority. The
SVZ was dissected from coronal slices of newborn rat brains, dissociated
mechanically, and trypsinized as described previously (Lim et al., 2000).
SVZ progenitors were purified using Percoll gradient centrifugation as de-
scribed previously (Lim et al., 2000) and seeded onto 0.24 mg/cm
 
2
 
 matri-
gel- or laminin-coated coverslips. Isolated cells were allowed to grow in
neurobasal medium supplemented with 20 ng/ml FGF-2 (human recombi-
nant; provided by P. Sarmientos, Farmitalia Carlo Erba, Milan, Italy), 1
 
 
 
B27, 2 mM glutamate, 1 mM sodium pyruvate, 2 mM 
 
N
 
-acetyl-cysteine,
and 1% penicillin–streptomycin. Cultures were fed every 3 d with fresh
medium containing 20 ng/ml FGF-2.
 
Immunocytochemistry
 
Immunostaining of cultures was performed as described previously (Wang
et al., 1996; Vutskits et al., 2001). The following primary Abs and dilutions
were used: mouse mAb against nestin (Biogenesis; 1:300 dilution); mouse
mAb against A2B5 (Eisenbarth et al., 1979; hybridoma supernatant; ATCC;
1:5 dilution); Men B (Meningococcus group B) mouse IgM mAb (1:500 di-
lution) that specifically recognizes 
 
 
 
 2–8-linked PSA with chain length su-
perior to 12 residues (Rougon et al., 1986); anti-GalC (Ranscht et al., 1982)
mouse IgM mAb (culture supernatant; 1:5 dilution); Tuj mouse mAb di-
rected against 
 
 
 
-tubulin isotype III (Sigma-Aldrich; 1:400 dilution); a rabbit
polyclonal Ab to GFAP (Dakopatts; 1:200 dilution); a rabbit polyclonal Ab
against NG2 (Chemicon International; 1:400 dilution); a goat polyclonal
Ab against Doublecortin (Santa Cruz Biotechnology, Inc.; 1:300 dilution);
a mouse mAb against Neu N (Chemicon International; 1:100 dilution). The
rabbit antiserum directed against the NCAM protein core was a site-
directed Ab recognizing the seven NH
 
2
 
-terminal residues of NCAM
(1:1,000 dilution; Rougon and Marshak, 1986). O4 mAb (hybridoma su-
pernatant, 1:5 dilution; Eisenbarth et al., 1979) was used to identify undif-
ferentiated oligodendrocytes. Hoechst 33258 was used to counterstain cell
nuclei in some cases. Fluorescence was examined with a fluorescence
microscope (model Axiophot; Carl Zeiss MicroImaging, Inc.). Controls
treated with nonspecific mouse IgM, IgG preimmune sera, or secondary
Abs alone showed no staining. In double immunolabeling experiments,
the use of only one primary Ab followed by the addition of both anti–
mouse FITC and anti–rabbit TRITC-conjugated secondary Abs resulted
only in single labeling. Proliferating cells were identified with an mAb
against BrdU (Boehringer; 1:50 dilution) after 20-h incorporation. 
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Migration assays using Dunn chamber
 
Chemotaxis of neural progenitors was directly viewed and recorded in sta-
ble concentration gradients of VEGF (human recombinant, 165–amino
acid homodimeric form; PeproTech) using the Dunn chemotaxis chamber
(Weber Scientific international Ltd.; Zicha et al., 1991; Allen et al., 1998).
(Recombinant human VEGF-C
 
 
 
N
 
 
 
C
 
 [provided by M. Skobe, Cancer Center,
Mount Sinai Medical Center, New York, New York] was used in some ex-
periments.) This device is made from a Helber bacteria counting chamber
by grinding a circular well in the central platform to leave a 1-mm-wide
annular bridge between the inner and the outer wells. Chemoattractants
added to the outer well of the device will diffuse across the bridge to the
inner blind well of the chamber and form a gradient. This apparatus allows
one to determine the direction of migration in relation to the direction of
the gradient. Coverslips with cells were inverted onto the chamber and cell
migration was recorded through the annular bridge between the concen-
tric inner and outer wells, and a period of 2 h was chosen to assess cell mi-
gration. In this work, we applied a systematic sampling, and all cells
within the migration region of the chamber were recorded and analyzed.
Data were recorded every 10 min using a 10
 
 
 
 objective (Carl Zeiss Micro-
Imaging, Inc.) via a CCD video camera (Hamamatsu) using Openlab soft-
ware. In these chemotaxis experiments, the outer well of the Dunn cham-
ber was filled with medium containing 200 ng/ml VEGF and 20 ng/ml
FGF-2 and the concentric inner well with only medium and FGF-2. For
chemokinesis experiments, 20 ng/ml VEGF or 20 ng/ml FGF-2 was added
to both the outer and inner wells of the Dunn chamber. MF1, a VEGFR1
blocking Ab, DC101, and a VEGFR2 blocking Ab (both added at 20 
 
 
 
g/ml;
provided by D. Hicklin, ImClone Systems Inc., New York, NY) were used
to block the function of the corresponding VEGFR. A polysialic acid block-
ing Ab was used as a control.
Directionality of cell movement was analyzed using scatter diagrams of
cell displacement. The diagrams were oriented so that the position of the
outer well of the chamber was vertical (y direction). Each point represents
the final positions of the cells at the end of the recording period where the
starting point of migration is fixed at the intersection of the two axes.
To determine the efficiency of forward migration during the 2-h record-
ing period, the FMI was calculated as the ratio of forward progress (net dis-
tance the cell progressed in the direction of VEGF source) to the total path
length (total distance the cell traveled through the field; Foxman et al.,
1999). FMI values were negative when cells moved away from the source
of VEGF. The cell speed was calculated for each lapse interval recorded
during the 2-h period.
 
RNA purification and RNase protection assay
 
Neural progenitors at 6 d of culture in FGF-2 or after 12-h starvation of
FGF-2 were used for RNA preparation. Total cellular RNA was purified us-
ing TRIzol reagent (Invitrogen). RNase protection assays were performed
using cRNA probes for rat VEGFR1 and VEGFR2 as described by Pepper et
al. (2000).
 
Immunoprecipitation and Western blotting
 
Neural progenitors from the normal cultures in FGF-2 or from cultures
starved of FGF-2 for 12 h were lysed, and VEGFR2 protein was immuno-
precipitated from cell lysates with a polyclonal Ab (sc-504; Santa Cruz
Biotechnology, Inc.) recognizing amino aids 1158–1345 in the mouse
VEGFR2 COOH terminus. Western blot was performed with a polyclonal
anti-VEGFR2 Ab (sc-315; Santa Cruz Biotechnology, Inc.) recognizing the
mouse COOH-terminal amino acids 1348–1367.
 
SVZ explants cultures
 
The frontal lobes of the brains of 1-d-old Sprague-Dawley rat pups (Sizv)
were isolated and cut into 300-
 
 
 
m-thick coronal sections with a McIllwain
tissue chopper. From these slices, the anterior part of the SVZ was micro-
dissected. SVZ explants were embedded in a collagen matrix and cultured
for 7 d in chemically defined serum-free medium (50% DME [GIBCO
BRL], 50% F12, Hepes, Tris-HCl, and complemented with 20 
 
 
 
g/ml trans-
ferrin human, 100 
 
 
 
M putrescine, 30 nM sodium selenite, 1 nM triiodo-
thyronin, 0.5 
 
 
 
g/ml docosahexaenoic acid, 1 
 
 
 
g/ml arachidonic acid, and
insulin 60 U/liter) under 5% CO
 
2
 
. The medium was changed every third
day. For coculture experiments, SVZ explants were cultured in the pres-
ence of murine C
 
2
 
C12 myoblasts that had been engineered to secret VEGF
(Rinsch et al., 2001). C2C12 cells were suspended in a drop of collagen ma-
trix that was placed at a distance of  1,000  m from the SVZ explant. As a
control, mock-transfected cells of the same origin were placed into the col-
lagen matrix in a similar manner and at the same distance, but on the op-
posite side of the explant.
Cell migration was assessed at the end of 7 d in culture. We established
three categories: (1) no migration, occurring when no or only a few cells
emigrated from the explants; (2) symmetrical migration, occurring when
numerous cells had left the explants, the distance of the migrating front of
the cells exceeded 50  m in random directions; and (3) asymmetrical or
directional migration, occurring when the distance of the migrating front
was at least twice of that on the other side and exceeded 50  m.
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